Grants & Projects per year
Personal profile
Fingerprint
Dive into the research topics where Theodore Gabig is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
GO44900: A Phase Ib Study Evaluating Safety Efficacy Pharmacokinetics & Pharmacodynamics of Glofitamab in Comination with Gemcitabine plus Oxaliplatin in Patients from Racial-Ethnic Minorities with Relapsed or Refractory Diffuse Cell Lympho
Gabig, T. (CoI), Jandl, T. (CoI), Lan, F. (CoI), Lee, C. (CoI), Liu, S. (CoI) & Schuster, M. (CoI)
05/1/26 → 01/28/27
Project: Research
-
Ntrust-2: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy in Subjects with Immune-Mediated Diseases
Schuster, M. (PI), Gabig, T. (CoPI), Jandl, T. (CoPI), Lan, F. (CoPI), Lee, C. (CoPI) & Liu, S. (CoPI)
05/5/25 → 02/3/27
Project: Research
-
GO43878: A Phase III, Open-label, Multicenter, Randomized Study Evaluating Glofitamab as a Single Agent Versus Investigator's Choice in Patients With Relapsed/Refractory Mantle Cell Lymphoma
Gabig, T. (CoI), Jandl, T. (CoI), Lan, F. (CoI), Lee, C. (CoI), Liu, S. (CoI) & Schuster, M. (CoI)
06/26/26 → 08/29/26
Project: Research
-
Ntrust-1: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with Autoimmune Disease
Yao, Q. P. (PI), Gabig, T. (CoPI), Jandl, T. (CoPI), Lan, F. (CoPI), Lee, C. (CoPI), Liu, S. (CoPI) & Schuster, M. (CoPI)
05/16/25 → 08/19/26
Project: Research
-
ICT-8 Efficacy Study of Inecalcitol in Combination with Decitabine in Acute Myeloid Patients Unfit for Standard Chemotherapy
Gabig, T. (CoPI), Lan, F. (CoPI), Schuster, M. (CoPI), Salman, H. (PI) & Kiner-Strachan, B. (CoPI)
10/27/17 → 08/2/19
Project: Research
-
Aligning Thrombophilia Testing With Evidence-Based Guidelines: The Impact of Clinical Decision Support Redesign in an Academic Medical Center
Ung, L., Lee, M. H., Raju, S., Li, L. Z., Senzel, L., Guido, M., Gabig, T. G., Bobek, R. M., Tharakan, M., Lingam, V. & Wong, R., Sep 1 2026, In: American Journal of Medical Quality. 41, 5, p. 293-299 7 p.Research output: Contribution to journal › Article › peer-review
-
ras oncogene mediates paracrine interactions between leukemic progenitor cells and stromal elements
Derigs, H. G., Nahreini, T. S., Harrington, M. A., Burgess, G. S., English, D., Inhorn, L., Klingberg, D., Gabig, T. G. & Boswell, H. S., Jan 1 2018, Growth Regulation and Carcinogenesis: Volume I. CRC Press, p. 267-278 12 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer
Gabig, T. G., Waltzer, W. C., Whyard, T. & Romanov, V., Sep 16 2016, In: Biochemical and Biophysical Research Communications. 478, 2, p. 887-892 6 p.Research output: Contribution to journal › Article › peer-review
11 Scopus citations -
Refractory adult primary autoimmune neutropenia that responded to alemtuzumab
Neerukonda, A. R., Lan, F., Gabig, T. & Saraya, T., 2016, In: Internal Medicine. 55, 12, p. 1667-1670 4 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
A claudin 3 and claudin 4-targeted clostridium perfringens protoxin is selectively cytotoxic to PSA-producing prostate cancer cells
Romanov, V., Whyard, T. C., Waltzer, W. C. & Gabig, T. G., Sep 1 2014, In: Cancer Letters. 351, 2, p. 260-264 5 p.Research output: Contribution to journal › Article › peer-review
30 Scopus citations